Percentage of patients within recommended antithrombotic range after 1 × 3,000 IU/d, and 2 × 3,000 IU/d certoparin

<p><b>Copyright information:</b></p><p>Taken from "Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study"</p><p>Critical Care 2005;9(5):R541-R548.</p><p>Published online 9 Aug 2005</p><p>PMCID:PMC1297619.</p><p>Copyright © 2005 Jochberger et al.; licensee BioMed Central Ltd.</p